Liliane Robillard

2.7k total citations · 1 hit paper
23 papers, 1.7k citations indexed

About

Liliane Robillard is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Liliane Robillard has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Liliane Robillard's work include PARP inhibition in cancer therapy (8 papers), Neuroscience and Neuropharmacology Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Liliane Robillard is often cited by papers focused on PARP inhibition in cancer therapy (8 papers), Neuroscience and Neuropharmacology Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Liliane Robillard collaborates with scholars based in United States, Canada and United Kingdom. Liliane Robillard's co-authors include Harold A. Chapman, Matthias C. Kugler, Kevin K. Kim, Michael G. Galvez, Paul J. Wolters, Dean Sheppard, Alexis N. Brumwell, Paul R. Albert, Ying Wei and Chi‐Hui Tang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Liliane Robillard

23 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix

2006 1.0k citations Kevin K. Kim, Matthias C. Kugler et al. Proceedings of the National Academy of Sciences profile →

Peers

Liliane Robillard

PRM

ONCOL

Kyle N. Cowan Canada

Paola Riva Italy

Fumihiro Higashino Japan

Anat Erdreich‐Epstein United States

John C. Sok United States

Natsuki Takaha Japan

Rebecca Sowers United States

Božo Krušlin Croatia

Ryoko Shimizu‐Hirota Japan

Kevin Du United States

Kyle N. Cowan Canada

Liliane Robillard

628 ×0.8

PRM

1.0k ×1.4

96 ×0.3

ONCOL

250 ×1.0

144 ×1.0

Citations per year, relative to Liliane Robillard Liliane Robillard (= 1×) peers Kyle N. Cowan

Countries citing papers authored by Liliane Robillard

Since Specialization

Citations

This map shows the geographic impact of Liliane Robillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liliane Robillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liliane Robillard more than expected).

Fields of papers citing papers by Liliane Robillard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liliane Robillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liliane Robillard. The network helps show where Liliane Robillard may publish in the future.

Co-authorship network of co-authors of Liliane Robillard

This figure shows the co-authorship network connecting the top 25 collaborators of Liliane Robillard. A scholar is included among the top collaborators of Liliane Robillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liliane Robillard. Liliane Robillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zboralski, Dirk, Frank Osterkamp, Aileen Hoehne, et al.. (2023). Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2621–2635. 27 indexed citations

Robillard, Liliane, Mingxiang Liao, Minh Nguyen, et al.. (2022). The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models. Journal of Immunotherapy. 45(8). 335–348. 4 indexed citations

Lopes, Jared E., Rachel L. Dusek, Liliane Robillard, et al.. (2020). Abstract 2202: The combination of a mouse ortholog of ALKS 4230, a selective agonist of the intermediate affinity IL-2 receptor, and the angiogenesis inhibitor lucitanib enhances antitumor activity. Cancer Research. 80(16_Supplement). 2202–2202. 2 indexed citations

Thủy, Nguyễn Minh, Liliane Robillard, Thomas C. Harding, et al.. (2019). Abstract 3888: Intracranial evaluation of the in vivo pharmacokinetics, brain distribution, and efficacy of rucaparib inBRCA-mutant, triple-negative breast cancer. 3888–3888. 2 indexed citations

Dusek, Rachel L., Liliane Robillard, Thomas C. Harding, Andrew D. Simmons, & Minh Nguyen. (2019). Abstract 1214: Enhancement of anti-PD-1 antitumor efficacy in syngeneic preclinical models by the angiogenesis inhibitor lucitanib. Cancer Research. 79(13_Supplement). 1214–1214. 2 indexed citations

Nguyen, Minh, Liliane Robillard, Kevin Lin, Thomas C. Harding, & Andrew D. Simmons. (2018). Abstract 1716: The PARP inhibitor rucaparib activates the STING pathway and enhances antitumor responses of immune checkpoint inhibitors in BRCA deficient syngeneic models. Cancer Research. 78(13_Supplement). 1716–1716. 4 indexed citations

Robillard, Liliane, Minh Nguyen, Thomas C. Harding, & Andrew D. Simmons. (2017). Abstract 2475: In vitro and in vivo assessment of the mechanism of action of the PARP inhibitor rucaparib. Cancer Research. 77(13_Supplement). 2475–2475. 17 indexed citations

Robillard, Liliane, Minh Nguyen, Andrea Loehr, et al.. (2017). Abstract 3650: Preclinical evaluation of the PARP inhibitor rucaparib in combination with PD-1 and PD-L1 inhibition in a syngeneic BRCA1 mutant ovarian cancer model. Cancer Research. 77(13_Supplement). 3650–3650. 13 indexed citations

Gnad, Florian, Jeffrey J. Wallin, Kyle A. Edgar, et al.. (2016). Quantitative phosphoproteomic analysis of the PI3K‐regulated signaling network. PROTEOMICS. 16(14). 1992–1997. 4 indexed citations

10.

Lin, Kevin, James Sun, Lara Maloney, et al.. (2015). 2701 Quantification of genomic loss of heterozygosity enables prospective selection of ovarian cancer patients who may derive benefit from the PARP inhibitor rucaparib. European Journal of Cancer. 51. S531–S532. 13 indexed citations

11.

Robillard, Liliane, et al.. (2014). 249 Preclinical efficacy of the PARP inhibitor rucaparib (CO-338/AG014699/PF-01367338) in pancreatic cancer models with homologous recombination deficiencies (HRD). European Journal of Cancer. 50. 83–83. 1 indexed citations

12.

Robillard, Liliane, Thomas C. Harding, & Annette O. Walter. (2013). Abstract 3349: Preclinical efficacyof the PARP inhibitor rucaparib (AG014699/PF-01367338) as a monotherapy and incombination with PI3K inhibition.. Cancer Research. 73(8_Supplement). 3349–3349. 2 indexed citations

13.

Vijapurkar, Ulka, Liliane Robillard, Michael Degtyarev, et al.. (2012). mTOR kinase inhibitor potentiates apoptosis of PI3K and MEK inhibitors in diagnostically defined subpopulations. Cancer Letters. 326(2). 168–175. 6 indexed citations

14.

Morris, Stephen J., et al.. (2007). Differential desensitization of dopamine D2 receptor isoforms by protein kinase C: The importance of receptor phosphorylation and pseudosubstrate sites. European Journal of Pharmacology. 577(1-3). 44–53. 22 indexed citations

15.

Kim, Kevin K., Matthias C. Kugler, Paul J. Wolters, et al.. (2006). Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proceedings of the National Academy of Sciences. 103(35). 13180–13185. 1031 indexed citations breakdown →

16.

Wei, Ying, Chi‐Hui Tang, Young Hyo Kim, et al.. (2006). Urokinase Receptors Are Required for α5β1 Integrin-mediated Signaling in Tumor Cells. Journal of Biological Chemistry. 282(6). 3929–3939. 84 indexed citations

17.

Mirshahi, Tooraj, Liliane Robillard, Hailin Zhang, Terence E. Hébert, & Diomedes E. Logothetis. (2002). Gβ Residues That Do Not Interact with Gα Underlie Agonist-independent Activity of K+ Channels. Journal of Biological Chemistry. 277(9). 7348–7355. 43 indexed citations

18.

Albert, Paul R. & Liliane Robillard. (2002). G protein specificity. Cellular Signalling. 14(5). 407–418. 141 indexed citations

19.

Liu, Gele, Liliane Robillard, Behzad Banihashemi, & Paul R. Albert. (2002). Growth Hormone-induced Diacylglycerol and Ceramide Formation via Gαi3 and Gβγ in GH4 Pituitary Cells. Journal of Biological Chemistry. 277(50). 48427–48433. 9 indexed citations

20.

Robillard, Liliane, Nathalie Éthier, Mathieu Lachance, & Terence E. Hébert. (2000). Gβγ subunit combinations differentially modulate receptor and effector coupling in vivo. Cellular Signalling. 12(9-10). 673–682. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact